What type of drug is metformin, and what is its primary mechanism of action?

What type of drug is metformin, and what is its primary mechanism of action?

• A. Insulin and increases glucose uptake
• B. Oral hypoglycemic agent that improves insulin sensitivity and decreases hepatic glucose production
• C. Sodium-glucose co-transporter 2 (SGLT2) inhibitor that increases glucose excretion
• D. GLP-1 receptor agonist that decreases appetite

Answer: (B)

Metformin is classified as an oral hypoglycemic agent primarily used in the management of type 2 diabetes. Its primary mechanism of action involves improving insulin sensitivity, which allows for better utilization of glucose by the body's cells. Additionally, metformin decreases hepatic glucose production, particularly by reducing gluconeogenesis in the liver. This dual action helps to lower overall blood glucose levels in patients with insulin resistance, which is a common feature of type 2 diabetes. Metformin does not function as an insulin replacement or directly increase glucose uptake like insulin itself does; instead, it enhances the body's own insulin sensitivity and is particularly beneficial in improving metabolic control. This is a key reason why the identification of metformin as an oral hypoglycemic agent that improves insulin sensitivity and decreases hepatic glucose production is accurate. Other options describe different classes of medications that serve distinct roles in diabetes management, but they do not accurately depict metformin's mechanism of action. Such nuanced understanding is important in the clinical application of diabetes therapies.

Metformin is classified as an oral hypoglycemic agent primarily used in the management of type 2 diabetes. Its primary mechanism of action involves improving insulin sensitivity, which allows for better utilization of glucose by the body's cells. Additionally, metformin decreases hepatic glucose production, particularly by reducing gluconeogenesis in the liver. This dual action helps to lower overall blood glucose levels in patients with insulin resistance, which is a common feature of type 2 diabetes.

Metformin does not function as an insulin replacement or directly increase glucose uptake like insulin itself does; instead, it enhances the body's own insulin sensitivity and is particularly beneficial in improving metabolic control. This is a key reason why the identification of metformin as an oral hypoglycemic agent that improves insulin sensitivity and decreases hepatic glucose production is accurate.

Other options describe different classes of medications that serve distinct roles in diabetes management, but they do not accurately depict metformin's mechanism of action. Such nuanced understanding is important in the clinical application of diabetes therapies.